Feng Zhang is a core institute member of the Broad Institute of MIT and Harvard, as well as an investigator at the McGovern Institute for Brain Research at MIT, co-director of the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics at MIT, the James and Patricia Poitras Professor of Neuroscience at MIT, and a professor at MIT, with joint appointments in the departments of Brain and Cognitive Sciences and Biological Engineering. Zhang is also an investigator at the Howard Hughes Medical Institute. Zhang is a molecular biologist seeking to improve human health by discovering approaches to modulate cellular programs, including returning diseased, stressed, or aged cells to a more healthful state. These approaches include developing molecular technologies for modifying the cell’s genetic information and the delivery vehicles needed to get these tools into the right cells as well as larger-scale engineering to restore organ function. Zhang hopes to apply these approaches to neurodegenerative diseases, immune disorders, aging, and other disease contexts. He is also an advisor to numerous companies, including scientific founder at Moonwalk Biosciences, and epigenetics biotech.